Home Cart Sign in  
Chemical Structure| 68370-47-8 Chemical Structure| 68370-47-8

Structure of Micheliolide
CAS No.: 68370-47-8

Chemical Structure| 68370-47-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Micheliolide attenuates high glucose-induced NF-κB activation, IκBα degradation, and the expression of MCP-1, TGF-β1, and FN in mouse mesangial cells.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Micheliolide

CAS No. :68370-47-8
Formula : C15H20O3
M.W : 248.32
SMILES Code : O=C(O[C@@]1([H])[C@@]2([H])CCC(C)=C3CC[C@@](C)(O)[C@@]31[H])C2=C
MDL No. :MFCD27953044
InChI Key :RDJAFOWISVMOJY-PWNZVWSESA-N
Pubchem ID :442279

Safety of Micheliolide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H315-H319
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Micheliolide

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
THP-1-derived macrophages 10 μM 48 hours MCL inhibited ox-LDL-induced macrophage ferroptosis, improved cell viability, reduced LDH release, ameliorated mitochondrial function, decreased lipid ROS levels, and increased GPX4 and xCT expression. Redox Biol. 2024 Feb;69:102987
KG-1a 3.9-16.2 μM (IC50) 48 hours Inhibited growth of various cancer cell lines, with leukemia cell lines being more sensitive to DMAMCL J Med Chem. 2018 May 10;61(9):4155-4164
K562 3.9-16.2 μM (IC50) 48 hours Inhibited growth of various cancer cell lines, with leukemia cell lines being more sensitive to DMAMCL J Med Chem. 2018 May 10;61(9):4155-4164
HL-60 3.9-16.2 μM (IC50) 48 hours Inhibited growth of various cancer cell lines, with leukemia cell lines being more sensitive to DMAMCL J Med Chem. 2018 May 10;61(9):4155-4164
T47DTAMR cells 5 μM MCL inhibited the expression of ASAH1 and cell proliferation, especially in MCF7TAMR and T47DTAMR cells. Cell Prolif. 2024 Nov;57(11):e13700
MCF7TAMR cells 5 μM MCL inhibited the expression of ASAH1 and cell proliferation, especially in MCF7TAMR and T47DTAMR cells. Cell Prolif. 2024 Nov;57(11):e13700
Hepa 1–6 10 μM, 20 μM, 30 μM 24 hours MCL significantly inhibited the growth of Hepa 1–6 cells by triggering immunogenic cell death (ICD) through ROS-mediated endoplasmic reticulum stress (ERS). Redox Biol. 2022 Aug;54:102351
HepG2 10 μM, 20 μM, 30 μM 24 hours MCL significantly inhibited the growth of HepG2 cells by triggering immunogenic cell death (ICD) through ROS-mediated endoplasmic reticulum stress (ERS). Redox Biol. 2022 Aug;54:102351
Bone marrow-derived macrophages (BMDMs) 5 μM 24 hours To assess the effect of MCL on the survival and growth of BMDMs, the results showed that MCL had minimal toxicity to BMDMs at a concentration of 5 μM. J Transl Med. 2025 Feb 14;23(1):181
RAW264.7 cells 10 μM 24 hours To assess the effect of MCL on the survival and growth of RAW264.7 cells, the results showed that MCL had minimal toxicity to RAW264.7 cells at a concentration of 10 μM. J Transl Med. 2025 Feb 14;23(1):181
mouse tubular epithelial cells (mTECs) 0, 1.25, 2.5, 5, 10 μM 48 hours Investigate the effect of MCL on TGF-β1-induced EMT, results showed MCL significantly suppressed Mtdh expression and alleviated EMT Lab Invest. 2019 Jul;99(8):1092-1106
H460 cells 20 μM 6 hours To evaluate the killing effect of MCL on NSCLC cells, it was found that MCL had a weak killing effect on H460 cells. Int J Mol Sci. 2020 May 11;21(9):3392
Calu-1 cells 20 μM 6 hours To evaluate the killing effect of MCL on NSCLC cells, it was found that MCL inhibited cell growth in a dose-dependent manner. Int J Mol Sci. 2020 May 11;21(9):3392
H1299 cells 20 μM 6 hours To evaluate the killing effect of MCL on NSCLC cells, it was found that MCL inhibited cell growth in a dose-dependent manner. Int J Mol Sci. 2020 May 11;21(9):3392

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ApoE−/− mice High-fat diet-induced atherosclerosis model Oral gavage 100 mg/kg/day Once daily for 16 weeks MCL significantly attenuated atherosclerotic plaque progression, characterized by reduced plaque area, decreased lipid deposition, increased collagen content, and inhibited macrophage ferroptosis by elevating GPX4 and xCT levels. Redox Biol. 2024 Feb;69:102987
C57BL/6 mice Hepa 1–6 tumor model Intraperitoneal injection 25 mg/kg MCL significantly inhibited the growth of Hepa 1–6 tumors and stimulated immune responses by inducing immunogenic cell death (ICD). Redox Biol. 2022 Aug;54:102351

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.03mL

0.81mL

0.40mL

20.14mL

4.03mL

2.01mL

40.27mL

8.05mL

4.03mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories